Core Viewpoint - China CNR recently signed significant contracts totaling approximately 32.92 billion yuan, which accounts for about 13.4% of the company's projected revenue for 2024 under Chinese accounting standards [2] Group 1: Recent Contracts and Financial Performance - In mid-May, China CNR announced additional contracts worth approximately 54.74 billion yuan, representing about 22.2% of the projected 2024 revenue [2] - In Q1 2025, China CNR achieved revenue of 48.67 billion yuan, a year-on-year increase of 51.23%, with net profit reaching 3.05 billion yuan, up 202.79% [2] - The significant growth in Q1 performance was attributed to increased revenue from railway equipment, particularly in the areas of high-speed trains and freight cars, with some new orders from late 2024 being delivered in Q1 2025 [2] Group 2: Future Outlook - For the year, China CNR expects stable overall demand for railway equipment compared to last year, although the structure of demand may change [3] - The company anticipates a significant increase in new orders for urban rail vehicles, with delivery levels expected to remain comparable to 2024 [3] Group 3: Profit Forecast - In early July, China CNR projected a net profit for the first half of 2025 to be between 6.72 billion and 7.56 billion yuan, an increase of 2.52 billion to 3.36 billion yuan compared to the same period last year, representing a year-on-year growth of 60% to 80% [5] - The expected non-net profit for the same period is projected to be between 6.22 billion and 7.06 billion yuan, reflecting an increase of 2.86 billion to 3.70 billion yuan, with a year-on-year growth of 85% to 110% [5] - The anticipated growth is primarily due to increased product sales compared to the previous year [5] Group 4: Historical Performance - Over the past decade, China CNR's annual net profit growth rate has consistently hovered around zero [4]

中国中车7月29日公告，公司及下属企业于近期（主要为2025年5月至7月）签订了若干项重大合同，合 计金额约329.2亿元人民币。 ...

格隆汇7月29日丨中国中车(01766.HK)发布公告，公司及下属企业于近期（主要为2025年5月至7月）签 订了若干项重大合同，合计金额约329.2亿元人民币，上述合同总金额约占公司中国会计准则下2024年 营业收入的13.4%。 ...

格隆汇7月29日丨中国中车(01766.HK)发布公告，公司及下属企业于近期（主要为2025年5月至7月）签 订了若干项重大合同，合计金额约329.2亿元人民币，上述合同总金额约占公司中国会计准则下2024年 营业收入的13.4%。 ...

Core Viewpoint - China CNR Corporation Limited (01766) has recently signed several significant contracts totaling approximately 32.92 billion RMB, primarily between May and July 2025, indicating strong business activity and growth potential in various sectors [1][2] Group 1: Contract Details - The company’s subsidiaries signed urban rail vehicle sales and maintenance contracts worth approximately 14.34 billion RMB with clients including the São Paulo Metro and Shanghai Shentong Metro Construction Group [1] - Contracts for locomotive repair totaling about 6.9 billion RMB were signed with various subsidiaries of China National Railway Group [1] - Wind power and energy storage equipment sales contracts amounting to approximately 4.03 billion RMB were established with several energy companies [1] - Sales contracts for power concentrated multiple units worth around 3.02 billion RMB were signed with China National Railway Group [1] Group 2: Additional Contracts - Freight car sales contracts totaling approximately 2.55 billion RMB were signed with China National Railway Group [2] - Passenger car repair contracts worth about 2.08 billion RMB were also established with subsidiaries of China National Railway Group [2] - The total value of these contracts represents approximately 13.4% of the company's projected revenue for 2024 under Chinese accounting standards [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 中國中車股份有限公司 CRRC CORPORATION LIMITED （於中華人民共和國註冊成立的股份有限公司） （股份代碼：1766） 上述合同總金額約佔本公司中國會計準則下2024年營業收入的13.4%。 承董事會命 中國中車股份有限公司 孫永才 董事長 中國‧北京 2025年7月29日 海外監管公告 簽訂合同公告 此海外監管公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條發出。 中國中車股份有限公司（「本公司」）及下屬企業於近期（主要為2025年5月至7月）簽訂了 若干項重大合同，合計金額約329.2億元人民幣，具體情況如下： 1 1. 本公司下屬企業與巴西聖保羅地鐵公司（S e c r e t a r i a d o s T r a n s p o r t e s Metropolitanos Companhia do Metropolitano de São Paulo - Me ...

格隆汇7月29日丨中国中车(601766.SH)公布，公司及下属企业于近期（主要为2025年5月至7月）签订了 若干项重大合同，合计金额约329.2亿元人民币。 ...

Core Insights - Aerospace Information Co., Ltd. has won the bid for the construction of a smart tax management platform for China CNR Corporation Limited, aiming to create an industry-leading and highly intelligent tax management hub [1] Group 1 - The project will drive the transformation of tax operation models towards digitalization, centralization, and intelligence [1]

Major Events - Xizang Tianlu announced that its convertible bond "Tianlu Convertible Bond" experienced significant abnormal trading fluctuations, with a cumulative closing price increase of over 100% from July 21 to July 29, 2025, closing at 481.80 yuan per bond, representing a premium of 381.80% over the face value and a conversion premium rate of 16.60% [1] - Huqin Technology plans to acquire 6% of Jinghe Integrated's shares for 2.393 billion yuan, purchasing 120 million shares at a price of 19.88 yuan per share, marking its first stake in the company [2] - Liyuan Technology's actual controller, Shen Wanzhong, received a criminal judgment for violating information disclosure regulations, sentenced to one year in prison with a one and a half year probation, and fined 3.3 million yuan, but this will not significantly impact the company's operations [3] - Huashi Technology announced the lifting of detention measures against its actual controller and general manager, Ye Jianbiao, allowing him to resume his duties [4] - Dongfang Materials' chairman, Xu Guangbin, resigned due to personal reasons but will continue as a board member [5] - WuXi AppTec adjusted its share repurchase price limit from 90.72 yuan to 114.15 yuan per share [6] Performance Overview - Greenland Holdings reported a contract sales amount of 21.752 billion yuan in Q2 2025, a year-on-year increase of 16.93%, with a total sales area of 2.217 million square meters, up 31.03% from the previous year [7] - Lujiazui's H1 2025 net profit was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [8] - Hongfa Co. achieved a net profit of 964 million yuan in H1 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [9] - Nanya New Materials expects a net profit of 80 million to 95 million yuan in H1 2025, representing a year-on-year increase of 44.69% to 71.82% due to increased sales and improved product structure [9] - Sains expects a net profit decline of 57.53% to 60.13% in H1 2025, with revenue between 410 million and 440 million yuan, a year-on-year increase of 15.17% to 23.59% [9] - Baotai anticipates a net loss of 110 million to 140 million yuan in H1 2025, a reduction in losses compared to the previous year, attributed to increased sales of a specific product and reduced R&D expenses [9] Major Contracts - China CNR announced the signing of several major contracts totaling approximately 32.92 billion yuan, accounting for 13.4% of its projected revenue for 2024 [10] - Wantong Zhikong signed an exclusive authorization agreement with Shanghai Shenming Aosi Semiconductor Technology for the sales and cooperation in the field of embodied intelligence [11] - Anhui Construction won a bid for a highway concession project in Chongqing, with an estimated total investment of 3.614 billion yuan [11] Shareholding Changes - Jiahe Meikang's shareholder, Guoshou Chengda, plans to reduce its stake by up to 3% through various trading methods [12] - Lanfeng Biochemical's shareholder, Hainan Wenqin, intends to reduce its stake by up to 2.61% [12]

Group 1 - Anhui Construction won a joint bid for the Chongqing Rongchang to Sichuan Zigong expressway project, with a total estimated investment of 3.614 billion yuan and a construction period of 3 years [1] - Hongfa Co. reported a net profit of 964 million yuan for the first half of 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [1][2] - Lujiazui's net profit for the first half of 2025 was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [3] - Enhua Pharmaceutical achieved a net profit of 700 million yuan, up 11.38%, with revenue of 3.010 billion yuan, an increase of 8.93% [4][5] - China CNR signed several major contracts totaling approximately 32.92 billion yuan, covering various sectors including urban rail vehicles and wind power equipment [6] - WanTong Intelligent signed an exclusive sales and cooperation agreement in the embodied intelligence field, gaining global sales rights for specific chip-based products [7][8] Group 2 - Liansheng Technology's subsidiary received a government subsidy of 13.5 million yuan, accounting for 12.24% of the company's latest audited net profit [9] - Guobang Pharmaceutical reported a net profit of 456 million yuan, a year-on-year increase of 12.60%, with revenue of 3.026 billion yuan, up 4.63% [10] - Baotai expects a net loss of 110 to 140 million yuan for the first half of 2025, a reduction in loss compared to the previous year [11] - Sains expects a net profit decrease of 57.53% to 60.13%, with projected revenue growth of 15.17% to 23.59% [12] - Nanya New Materials anticipates a net profit of 80 to 95 million yuan for the first half of 2025, an increase compared to the previous year [13] - Tian Pharmaceutical's subsidiary passed the consistency evaluation for a peritoneal dialysis solution [14] Group 3 - Shede Liquor announced the resignation of director Ni Qiang due to work reasons [15] - Greentown Water plans to transfer assets and liabilities of its ASEAN subsidiary to improve resource allocation [16] - Beibu Gulf Port's subsidiary signed an associated transaction contract worth 11.199 million yuan [17] - Beibu Gulf Port announced multiple resignations of directors and executives [18] - Jidian Co. reported the resignation of its deputy general manager due to work changes [19] - Wanhua Chemical's industrial park in Fujian resumed production after maintenance [20] Group 4 - Shanghai Pharmaceuticals received approval for a clinical trial of a new indication for its B019 injection [21] - Jianbang Co. reported a net profit of 69.66 million yuan, a decrease of 27.72%, with revenue of 307 million yuan, down 15.37% [23] - Jianbang Co. plans to use up to 400 million yuan of idle funds for cash management [25] - Wanfu Bio's subsidiary obtained multiple medical device registrations [28] - Hunan Tianyan announced a change in its controlling shareholder to China Chang'an Automobile Group [29][30] - Xizhuang Co. plans to establish a joint venture for sustainable aviation fuel [32]